India waives import duty on COVID-19 drug Remdesivir

The government on Tuesday waived off the customs duty on imported Remdesivir injections and the drug’s active pharmaceutical ingredients (API) till October 31.

The central government has also exempted customs duty on the import of “Beta Cyclodextrin (SBEBCD)”, used in the manufacture of Remdesivir, subject to the condition that the importer follows the procedure set out in the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017, the finance ministry said in a notification.

“This should increase supply and reduce cost thus providing relief to patients,”

commerce and industry minister Piyush Goyal said in a tweet.

The duty was 10% earlier but total import levies would go up to 16.5% after IGST a 1% social welfare surcharge.

Remdesivir, API and formulation were placed under export ban on April 11 to increase the supply of the injection in the domestic market.

Oxygen supply

The total supply of liquid medical oxygen and cylinders in Delhi on Tuesday up to 3 PM was 355.33 MT and the total stock at hospitals was 508 MT.

As per sources, the total demand for oxygen and the quantity dispatched was 355.33 MT.


See also  FTSE 100 LIVE: Pompeo warns global stock exchanges to crackdown on Chinese companies


Please enter your comment!
Please enter your name here